Simon Ateba is Chief White House Correspondent for Today News Africa. Simon covers President Joe Biden, Vice President Kamala Harris, the U.S. government, the United Nations, the International Monetary Fund, the World Bank and other financial and international institutions in Washington D.C. and New York City.
The United States Food and Drug Administration on Thursday approved Gilead Sciences Inc.’s antiviral therapy remdesivir to treat COVID-19, even though a new and larger study led by the World Health Organization (WHO) last week concluded that the drug is not effective in treating patients with COVID-19. It does not help patients recover from COVID-19 and it does not reduce deaths, the study found.
